Probably BTX 1801 results are worthless as the results were far from what would be called a grant success. The eradication of Staf did not last long and this is not clinically useful. I think none of the pharmaceuticals may want to touch this thing unless they can prove it with more robust studies.
Probably BTX 1801 results are worthless as the results were far...
-
- There are more pages in this discussion • 7,495 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
37.5¢ |
Change
-0.005(1.32%) |
Mkt cap ! $687.8M | |||
| Open | High | Low | Value | Volume |
| 37.0¢ | 37.5¢ | 37.0¢ | $394.6K | 1.058M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 9 | 672033 | 37.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 37.5¢ | 37204 | 6 |
View Market Depth
| Last trade - 10.26am 19/07/2024 (20 minute delay) ? |
| BOT (ASX) Chart |